Sign in
Taking peopleNo phase

Comparing two eye procedures for keratoconus: cross-linking alone or with surface laser removal

Compares cross-linking alone with cross-linking plus laser treatment in adults with keratoconus.

Key facts

Who runs it
Oslo University Hospital
Where
Norway1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Simultaneous pHototherapeutic Keratectomy and corneAl Collagen cRosslinking in Eyes With Keratoconus: a Randomized Trial (SHARK)
Status
Recruiting
People taking part
81 people, planned
Started
12 Feb 2024
Expected to end
1 Feb 2034
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Corneal collagen cross linking (CXL)
  • Transepithelial phototherapeutic keratectomy (t-PTK)
Record updated
16 February 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with keratoconus that is getting worse and needs corneal cross-linking (CXL). It compares CXL alone with CXL combined with t-PTK, a laser treatment of the cornea surface.

Age
18 years or older, no upper age limit
Sex
All sexes
Disease stage
Progressive keratoconus (a cone-shaped, thinning cornea that is getting worse) where CXL is needed
Biomarker or test result
Corneal thickness of at least 420 μm

Main reasons for not taking part

  • Another eye disease that causes poor vision

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit
  • Progressive keratoconus with indication for CXL
  • Corneal thickness ≥ 420 μm

Who cannot take part

  • Other eye disease causing visual impairment

This trial is currently available in Norway.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to compare CXL with combined treatment with CXL and t-PTK.

Read full original descriptionShow less

The main questions it aims to answer are whether combined treatment can give better visual acuity and if the treatments are equally safe.

The 2 groups in the trial

  • CXLExisting treatment, for comparison

    Treatment with CXL alone

    Treatment: Corneal collagen cross linking (CXL)

  • CXL and t-PTKTreatment being tested

    Treatment with t-PTK combined with CXL

    Treatment: Corneal collagen cross linking (CXL) and Transepithelial phototherapeutic keratectomy (t-PTK)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Simultaneous pHototherapeutic Keratectomy and corneAl Collagen cRosslinking in Eyes With Keratoconus: a Randomized Trial (SHARK)
Plain-language title
Comparing two eye procedures for keratoconus: cross-linking alone or with surface laser removalGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Record updated
16 February 2024